TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BDTX Stock 12 Month Forecast
Average Price Target
$9.00
▲(232.10% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Black Diamond Therapeutics in the last 3 months. The average price target is $9.00 with a high forecast of $10.00 and a low forecast of $8.00. The average price target represents a 232.10% change from the last price of $2.71.
trades and holding each position for 1 Month would result in 53.85% of your transactions generating a profit, with an average return of +4.02% per trade.
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +13.25% per trade.
Copying Robert Burns's trades and holding each position for 1 Year would result in 46.67% of your transactions generating a profit, with an average return of -9.83% per trade.
trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -8.18% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BDTX Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
2
5
5
7
7
Buy
2
1
1
1
1
Hold
0
0
0
0
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
6
6
8
10
In the current month, BDTX has received 8Buy Ratings, 2Hold Ratings, and 0Sell Ratings. BDTX average Analyst price target in the past 3 months is 9.00.
Each month's total comprises the sum of three months' worth of ratings.
BDTX Financial Forecast
BDTX Earnings Forecast
Next quarter’s earnings estimate for BDTX is -$0.18 with a range of -$0.23 to -$0.12. The previous quarter’s EPS was -$0.15. BDTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BDTX has Performed in-line its overall industry.
Next quarter’s earnings estimate for BDTX is -$0.18 with a range of -$0.23 to -$0.12. The previous quarter’s EPS was -$0.15. BDTX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BDTX has Performed in-line its overall industry.
BDTX Sales Forecast
Next quarter’s sales forecast for BDTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. BDTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BDTX has Performed in-line its overall industry.
Next quarter’s sales forecast for BDTX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. BDTX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BDTX has Performed in-line its overall industry.
BDTX Stock Forecast FAQ
What is BDTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Black Diamond Therapeutics’s 12-month average price target is 9.00.
What is BDTX’s upside potential, based on the analysts’ average price target?
Black Diamond Therapeutics has 232.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BDTX a Buy, Sell or Hold?
Black Diamond Therapeutics has a consensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings.
What is Black Diamond Therapeutics’s price target?
The average price target for Black Diamond Therapeutics is 9.00. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00 ,the lowest forecast is $8.00. The average price target represents 232.10% Increase from the current price of $2.71.
What do analysts say about Black Diamond Therapeutics?
Black Diamond Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of BDTX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.